Trials / Sponsors / GV20 Therapeutics
GV20 Therapeutics
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of GV20-0251 in Participants With Solid Tumor Malignancies Solid Tumor Cancer, Adult Refractory Cancer, Endometrial Carcinoma (EC) | Phase 1 / Phase 2 | 2025-07-11 |
| Recruiting | A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tu Solid Tumor, Adult, Refractory Cancer, Endometrial Carcinoma (EC) | Phase 1 / Phase 2 | 2023-03-23 |